Lowkey.. 😪 about Model S Plaid being discontinued.Roadster will of course be wild.. but Plaid just.. it will be missed.. https://t.co/qKlUATMbU3 ...

Hey @elonmusk any updates on roadster event ? https://t.co/qCYvPsIMPa ...

Elon Musk on Roadster"I feel confident saying it'll be the most exciting product unveil ever. I think it will be inspiring to a lot of people. And just it's, it's it's like the coolest car if it even is a car, that has ever existed. That will probably be the coolest car if it even is a car." ...

Group 1: Tesla's Developments - Tesla's Robotaxi fleet is expanding to new cities, including Henderson, Las Vegas, and is in the final validation phase for Cybercab vehicles in California[5] - Elon Musk confirmed the upcoming release of FSD v14.3, which enhances proactive reasoning capabilities compared to v14.2, and includes new features like automated parking and an upgraded smart summon[7] - The Terafab project aims to produce over 1 TW of AI computing power annually, addressing the current 20 GW output that meets only 2% of global demand[8] Group 2: Financial Metrics - Tesla's stock price is currently at $383.03, with a market capitalization of $1.44 trillion and a total share count of 3.752 billion[6] - The 52-week high and low for Tesla's stock are $498.83 and $214.25, respectively[6] - The book value per share is $21.90, indicating a strong asset base relative to its stock price[6] Group 3: Product Innovations - Tesla's new patent for an "electric vehicle range extender integration" could solve range issues for heavy-duty trucks by allowing dynamic power balancing between the main battery and auxiliary batteries[9] - The launch of the Roadster has been postponed to late April 2026, promising advanced technology integration[10] - Tesla has introduced the Model YL Premium six-seater in Thailand, priced at 1,999,000 Thai Baht, with plans for U.S. production[10] Group 4: Strategic Initiatives - Tesla is planning to launch Megapack operations in India, supported by government incentives for energy storage investments[11] - The company is investing $2.9 billion in advanced solar manufacturing equipment from Chinese suppliers to meet its goal of producing 100 GW of solar cells by 2028[12]

Core Insights - Tesla has successfully transitioned from its initial vision of electric vehicles to exploring robotics, AI, and driverless technology, indicating a significant evolution in its business strategy [2][12] - Hyundai Motor Group has announced a $6 billion investment in high-tech robotics, positioning itself as a competitor in the same technological space as Tesla [5][6] Group 1: Tesla's Evolution - Tesla's original vision of building a profitable electric vehicle brand has largely been realized, leading the company to pivot towards robotics and AI [1][2] - The company is in the final stages of developing its Optimus Gen 3 humanoid robot, with initial production expected by the end of 2026, aiming to be the "most advanced robot in the world" [9][11] Group 2: Hyundai's Competitive Move - Hyundai plans to produce 30,000 Atlas robots annually at its Metaplant in Georgia, USA, starting in 2028, with the goal of deploying these robots for assembly line tasks [10] - The acquisition of Boston Dynamics in 2021 has enabled Hyundai to enter the humanoid robotics market, which is projected to reach $5 trillion by 2050 according to Morgan Stanley [6][7] Group 3: Market Implications - The entry of Hyundai into the robotics space serves as a reminder that Tesla will face competition not only from new tech companies but also from established automotive rivals [12] - Investors are encouraged to reassess their investment strategies regarding Tesla as it ventures into new technological frontiers [11]

馬斯克又跳票了！ 你以為4月1號 就能看到 Roadster 那場史詩級 demo？ 結果他直接改口 可能要到 4月晚一些！ 九年了 粉絲等得 心都碎了 不過這次不一樣！ 二月Tesla剛提交 全新 Roadster商標 三月五號更狠 直接拿到 一體成型 複合材料 座椅專利！ 重量大減 剛性爆表 高速過彎時 你整個人 死死貼在椅子上 像穿上一件 一體化戰鬥服 馬斯克說這會是 炸裂級的神作 我信了 晚一點就晚一點 準備好 被震撼吧！. ...

大家好我是大鱼 马斯克又一次 把Roadster的 承诺往后推了 去年11 月他 信誓旦旦的 说4 月1 号 现在改口到四月底 这不是简单的跳票 而是Tesla把 最极致的 性能怪兽 留到所有 核心业务 都站稳之后 才肯放出来 全新商标 已经锁定设计 专利把座椅 直接变成第二底盘 种种迹象显示 这一次 Roadster真的要来了 大家不要错过 今天的精彩内容 OK let's go 第一部分 马斯克又跳票了！ 明明去年11月 马斯克还 信誓旦旦说 4月1号要来个 Roadster demo 结果现在他 直接改口 probably in late April 这种小延期 对粉丝来说 其实最折磨 Roadster从 2017年原型车 亮相到现在 已经被推了无数次 每次Tesla一忙着 量产Model 3 Y或者 Cybertruck 就会把这台 超跑先放一边 不过这其实也是 马斯克最 真实的一面 他永远把 核心业务排第一 绝不乱来 更重要的是 种种迹象显示 Roadster 已经箭在弦上 二月Tesla向 美国专利商标局 提交了全新的 Roadster商标申请 一个是拉长未来感的 ROADSTER字标 另一个则是 ...

New Roadster unveil hopefully next month.It will be a banger next-level.Jon Erlichman (@JonErlichman):On this day in 2008: production starts for Tesla’s first vehicle, the Roadster.https://t.co/95qmf4YqzW ...

True.New Roadster unveil probably in late April.Massimo (@Rainmaker1973):Today in 2008, Tesla began the regular production on its first car, the Tesla Roadster.Also, a reminder that there's one Tesla Roadster in an elliptical heliocentric orbit crossing the orbit of Mars. https://t.co/9Xh2A0DnrD ...

Group 1: Company Overview - HIMS & HERS HEALTH reported a revenue growth of 59% year-on-year, reaching $2.35 billion in 2025, with a net profit of $130 million[7] - The company has a market capitalization of $5.051 billion and a stock price of $22.16, with a target price of $31.10, indicating a potential upside of 41%[5][10] - The subscription base grew by 13% year-on-year to 2.51 million, with personalized subscription users increasing by 31% to 1.63 million, representing 65% of total subscriptions[8] Group 2: Financial Performance - Q4 2025 revenue was $620 million, a 28% increase, but gross margin decreased by 4.9 percentage points to 71.9%[7] - Adjusted EBITDA for 2025 was $318 million, with an adjusted EBITDA margin of 13.5%[7] - The company plans to achieve at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030[10] Group 3: Strategic Developments - HIMS & HERS is expanding internationally, with a $1.15 billion acquisition of Australia's largest telehealth platform, Eucalyptus, which has over 775,000 active paying users[8] - The company aims to exceed $1 billion in international revenue within three years, with 2025 international revenue at $140 million[8] - HIMS & HERS is transitioning to preventive healthcare, launching lab testing services and a longevity program in 2026[8] Group 4: Market Context - The GLP-1 drug market in the U.S. is projected to reach $100-150 billion by 2030, with HIMS & HERS shifting to sell Novo Nordisk's branded drugs after ceasing advertising for compounded semaglutide[9] - The company expects to leverage its platform and service advantages to capture significant market share despite lower margins on branded drugs[9]